The DNDi project portfolio is healthy, growing, and well-monitored. It has 20 projects - 10 in the discovery phase, 4 in preclinical development and 6 in the clinical phase.

DNDi's vision is to improve the quality of life & the health of people suffering from neglected diseases by developing new drugs or new formulations of existing drugs for patients suffering from these diseases.

Learn more about DNDi or read further information on neglected diseases.

See portfolio maps for specific therapeutic areas by clicking on diseases below:

Sleeping Sickness (HAT)

Kala Azar (VL)

Chagas disease

 

Read DNDi's full vision and mission statement here.

If you are involved in any other research related to neglected diseases, or would like to contribute to DNDi's work, please don't hesitate to get in touch.